|Trade names||Flovent, Flixotide, Flonase, others|
|Intranasal, inhaled, topical|
|Drug class||Steroids and steroid derivatives|
|Elimination half-life||10 hours|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||500.57 g·mol−1|
|3D model (JSmol)|
Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a steroid medication. When inhaled it is used for the long term management of asthma and COPD. In the nose it is used for hay fever and nasal polyps. It can also be used for mouth ulcers.
Common side effects when inhaled include upper respiratory tract infections, sinusitis, thrush, and cough. Common side effects when used in the nose include nosebleeding and sore throat. It works by decreasing inflammation.
Fluticasone propionate was patented in 1980, and approved for medical use in 1990. It is available as a generic medication. In the United States the wholesale cost per spray is about 0.33 USD as of 2018. In the United Kingdom, it costs the NHS about 0.13 GBP per spray as of 2019. In 2017, fluticasone was the 15th most commonly prescribed medication in the United States, with more than 32 million prescriptions (up from 16th place & 29 million in 2016).
Fluticasone propionate is used by powder or aerosol inhalation for the prophylaxis of asthma. The nasal spray is used for prevention and treatment of allergic rhinitis. Nasal drops are used in the treatment of nasal polyps. The nasal spray can also be used in the mouth for mouth ulcers.
If taken correctly, the nasal spray and oral inhaler formulation have fewer corticosteroid side effects than the tablet formulation because they limit systemic (blood) absorption. However, the systemic absorption is not negligible even with correct administration. Using the spray or inhaler at higher than recommended doses or with other corticosteroids can increase the risk for serious, systemic corticosteroid induced side effects. These side effects include weakened immune system, increased risk of systemic infections, osteoporosis, and elevated pressure in the eyes.
Common side effects may include nasal irritation (burning, stinging, bleeding), headache, upset stomach (nausea, vomiting), and diarrhea. Rare side effects include infection (evidenced by, e.g., fever, sore throat, and cough), vision problems, severe swelling, hoarse voice, and difficulty breathing or swallowing.
Common side effects may include upper respiratory tract infection, throat irritation, thrush, cough, and headache. Rare side effects include bruising, swelling of the face/neck, depression, tiredness, and shortness of breath.
This section does not cite any sources. (January 2020) (Learn how and when to remove this template message)
Fluticasone propionate is a highly selective agonist at the glucocorticoid receptor with negligible activity at androgen, estrogen, or mineralocorticoid receptors, thereby producing anti-inflammatory and vasoconstriction effects. It has been shown to have a wide range of inhibitory effects on multiple cell types (e.g. mast cell, eosinophil, neutrophil, macrophages, and lymphocytes) and mediators (e.g. histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation. Fluticasone propionate is stated to exert a topical effect on the lungs without significant systemic effects at usual doses, due to its low systemic bioavailability.
Ritonavir is a common drug used in the treatment of HIV. Coadministration of ritonavir and fluticasone may lead to increased levels of fluticasone in the body, which may lead to Cushing's Syndrome and adrenal insufficiency.
- "Fluticasone Use During Pregnancy". Drugs.com. 9 January 2019. Retrieved 31 January 2020.
- "Flonase Allergy Relief- fluticasone propionate spray, metered". DailyMed. 30 May 2019. Retrieved 31 January 2020.
- "Flovent Diskus- fluticasone propionate powder, metered". DailyMed. 7 January 2019. Retrieved 31 January 2020.
- "Cutivate- fluticasone propionate ointment". DailyMed. 18 February 2019. Retrieved 31 January 2020.
- "Flixonase Aqueous Nasal Spray - Summary of Product Characteristics (SmPC)". (emc). 25 October 2019. Retrieved 31 January 2020.
- "Fluticasone Propionate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 27 February 2019.
- "Fluticasone Propionate eent Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 27 February 2019.
- British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. pp. 262, 1172. ISBN 9780857113382.
- "Flixonase aqueous spray" (PDF). Sheffield Teaching Hospitals. June 2018. Retrieved 31 January 2020.
- Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495.
- "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
- "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
- "Fluticasone - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
- "Drugs & Medications". www.webmd.com. Retrieved 13 April 2020.
- "Prednisone and other corticosteroids: Balance the risks and benefits". Retrieved 4 March 2018.
- "Fluticasone Nasal Spray". AHFS Consumer Medication Information [Internet]. Bethesda (MD): American Society of Health-System Pharmacists, Inc. 1 September 2010 . Retrieved 2 November 2014.
- "Fluticasone Oral Inhalation". AHFS Consumer Medication Information [Internet]. Bethesda (MD): American Society of Health-System Pharmacists, Inc. 1 September 2010 . Retrieved 2 November 2014.
- Foisy MM, Yakiwchuk EM, Chiu I, Singh AE (July 2008). "Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature". HIV Medicine. 9 (6): 389–96. doi:10.1111/j.1468-1293.2008.00579.x. PMID 18459946.